Structure (Zonisamide 100mg Cap For Wockhardt 1)
Zonisamide
Product Images NDC 33261-843
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 33261-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Zonisamide 100mg Cap For Wockhardt 2)
The text appears to be a graph displaying the reduction in all partial seizure rates for patients undergoing treatment with zonisamide compared to those receiving a placebo. The graph shows a decrease in seizure rates over time for those on zonisamide, while the placebo group remains relatively unchanged. The information on the y-axis is not legible, but it appears to be a numerical scale ranging from 0 to 5300. No further information can be extracted from this text.*
Image Label (Zonisamide 100mg Cap For Wockhardt 3)
Zonisamide is a generic drug available in capsule form of 100mg strength, manufactured by Wockhardt Limited, India. Each capsule contains 100 mg of Zonisamide. The drug is used as a treatment for epileptic seizures and is a generic alternative to the brand name Zonegran. The dosage regimen should be followed as prescribed by a doctor and the package insert should be read before use. Store the medication away from children and direct sunlight.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
